| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.616 | 14.373 | 20.937 | 22.139 | 25.263 | 9.395 | 10.429 | 12.971 | 19.040 | 23.150 |
| Total Income - EUR | 13.616 | 14.373 | 24.221 | 22.139 | 25.263 | 9.408 | 10.429 | 12.971 | 19.040 | 23.150 |
| Total Expenses - EUR | 16.209 | 8.545 | 14.175 | 11.569 | 11.172 | 7.706 | 9.463 | 11.899 | 5.927 | 6.139 |
| Gross Profit/Loss - EUR | -2.593 | 5.829 | 10.046 | 10.570 | 14.092 | 1.702 | 966 | 1.072 | 13.113 | 17.010 |
| Net Profit/Loss - EUR | -2.994 | 5.397 | 9.417 | 9.906 | 13.334 | 1.419 | 659 | 683 | 10.681 | 14.080 |
| Employees | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Idex Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.045 | 1.035 | 1.312 | 1.660 | 1.505 | 1.357 | 1.832 | 1.586 | 1.365 | 1.192 |
| Current Assets | 5.671 | 7.497 | 13.337 | 22.493 | 30.424 | 31.270 | 24.885 | 13.917 | 9.747 | 15.627 |
| Inventories | 0 | 0 | 0 | 430 | 1.176 | 1.154 | 0 | 0 | 0 | 0 |
| Receivables | 110 | 109 | 144 | 1.545 | 690 | 677 | 1.064 | 664 | 1.691 | 2.294 |
| Cash | 5.561 | 7.388 | 13.194 | 20.517 | 28.558 | 29.439 | 23.821 | 13.254 | 8.056 | 13.333 |
| Shareholders Funds | 5.272 | 7.108 | 12.957 | 22.583 | 30.464 | 31.306 | 25.412 | 782 | 10.740 | 14.145 |
| Social Capital | 45 | 45 | 44 | 0 | 42 | 41 | 40 | 41 | 0 | 40 |
| Debts | 1.445 | 1.424 | 1.692 | 1.570 | 1.466 | 1.321 | 1.305 | 14.722 | 372 | 2.673 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Idex Med S.r.l.